Finance

Lists
BCLI:OTCMKTS
Brainstorm Cell Therapeutics Inc
$0.90
-8.16%
(-0.080) 1D
Sep 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCLI...
Open
$1.00
High
$1.00
Low
$0.85
Mkt. cap
9.93M
Avg. vol.
31.87K
Volume
26.80K
52-wk high
$1.69
52-wk low
$0.46
EPS
-$0.95
Beta
0.28
Shares outstanding
11.04M
No. of employees
19
Open
$1.00
High
$1.00
Low
$0.85
Mkt. cap
9.93M
Avg. vol.
31.87K
Volume
26.80K
52-wk high
$1.69
52-wk low
$0.46
EPS
-$0.95
Beta
0.28
Shares outstanding
11.04M
No. of employees
19
About Brainstorm Cell Therapeutics Inc
CEOChaim Lebovits | Stacy R. Lindborg
Employees19
Founded2000
Headquarters-
SectorBiotechnology
Websitebrainstorm-cell.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
899.00K
852.00K
762.00K
963.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.15M
1.39M
1.28M
2.65M
Operating expense
2.05M
2.24M
2.05M
3.61M
Total operating expenses
2.05M
2.24M
2.05M
3.61M
Operating income
-2.05M
-2.24M
-2.05M
-3.61M
Other non operating income
-
-
-
-
EBT including unusual items
-2.11M
-2.43M
-2.13M
-3.86M
EBT excluding unusual items
-2.11M
-2.43M
-2.13M
-3.86M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.11M
-2.43M
-2.13M
-3.86M
Net profit margin
-
-
-
-
Earnings per share
-0.19
-0.13
-0.19
-
Interest and investment income
-
-
-
-
Interest expense
-59.00K
-190.00K
-81.00K
-242.00K
Net interest expenses
-59.00K
-190.00K
-81.00K
-242.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.00M
-2.20M
-2.01M
-3.57M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps